Select all docs (Max 200)
Narrow Results:
Publication Year
- 2021 3
Medical Subject
- 2019-nCoV Vaccine mRNA-1273 1
- Adolescent 1
- Adult 2
- Aged 2
- Antibodies, Viral 1
- BNT162 Vaccine 1
- Cohort Studies 1
- CoronaVirus Infections 3
- COVID-19 2
- COVID-19 Vaccines 2
- COVID-19/Prevention & Control 1
- Female 2
- Hospitalization 3
- Hospitals, Veterans 2
- Humans 2
- Immunization Schedule 1
- Male 2
- Middle Aged 2
- Patient Acuity 1
- SARS-CoV-2 1
- Time Factors 1
- Vaccination 1
- Vaccine Efficacy 1
- Vaccines, Synthetic 2
- Veterans 2
- Veterans Health Services 1
- Young Adult 1
Personal Author
Corporate Author
- Baylor College of Medicine. Department of Medicine. 1
- CDC COVID-19 Response Team. 1
- COVID-19 Surveillance Group 2
- David Geffen School of Medicine. Department of Medicine. 1
- Emory University School of Medicine. Department of Medicine. 1
- General Dynamics Information Technology. 1
- Greater Los Angeles Veterans Affairs Healthcare System (U.S.). 1
- Icahn School of Medicine at Mount Sinai. Department of Medicine. 1
- James J. Peters Veterans Affairs Medical Center (Bronx, NY) 1
- Karna, LLC. 1
- Michael E. DeBakey Veterans Affairs Medical Center (Houston, Tex.) 1
- Rollins School of Public Health. Department of Global Health. 1
- Stanford University School of Medicine.Department of Medicine. 1
- SUPERNOVA COVID-19 Surveillance Group 2
- Surveillance Platform for Enteric and Respiratory Infectious Organisms at the VA (SUPERNOVA) 2
- United States Department of Veterans Affairs. 12Public Health Surveillance and Research. 1
- VA Palo Alto Health Care System (U.S.) 1
- Veterans Affairs Medical Center (Atlanta, Ga.) 1
Place as Subject
- U.S. 2
- United States 1
Resource Type General
Select all docs (Max 200)
1 -
3 of 3 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- 2019-nCoV Vaccine mRNA-1273 (1)
- Adolescent (1)
- Adult (2)
- Aged (2)
- Antibodies, Viral (1)
- BNT162 Vaccine (1)
- Cohort Studies (1)
- CoronaVirus Infections (3)
- COVID-19 (2)
- COVID-19 Vaccines (2)
- COVID-19/Prevention & Control (1)
- Female (2)
- Hospitalization (3)
- Hospitals, Veterans (2)
- Humans (2)
- Immunization Schedule (1)
- Male (2)
- Middle Aged (2)
- Patient Acuity (1)
- SARS-CoV-2 (1)
- Time Factors (1)
- Vaccination (1)
- Vaccine Efficacy (1)
- Vaccines, Synthetic (2)
- Veterans (2)
- Veterans Health Services (1)
- Young Adult (1)
- Baylor College of Medicine. Department of Medicine. (1)
- CDC COVID-19 Response Team. (1)
- COVID-19 Surveillance Group (2)
- David Geffen School of Medicine. Department of Medicine. (1)
- Emory University School of Medicine. Department of Medicine. (1)
- General Dynamics Information Technology. (1)
- Greater Los Angeles Veterans Affairs Healthcare System (U.S.). (1)
- Icahn School of Medicine at Mount Sinai. Department of Medicine. (1)
- James J. Peters Veterans Affairs Medical Center (Bronx, NY) (1)
- Karna, LLC. (1)
- Michael E. DeBakey Veterans Affairs Medical Center (Houston, Tex.) (1)
- Rollins School of Public Health. Department of Global Health. (1)
- Stanford University School of Medicine.Department of Medicine. (1)
- SUPERNOVA COVID-19 Surveillance Group (2)
- Surveillance Platform for Enteric and Respiratory Infectious Organisms at the VA (SUPERNOVA) (2)
- United States Department of Veterans Affairs. 12Public Health Surveillance and Research. (1)
- VA Palo Alto Health Care System (U.S.) (1)
- Veterans Affairs Medical Center (Atlanta, Ga.) (1)
- :Bajema, Kristina L. ;Dahl, Rebecca M.9 17 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) have been shown to be highly protective against COVID-19-associated hospitalizations (1-3). Data ...
- :Bajema, Kristina L. ;Dahl, Rebecca M.12 10 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):The mRNA COVID-19 vaccines (Moderna and Pfizer-BioNTech) provide strong protection against severe COVID-19, including hospitalization, for at least se...
- :Bajema, Kristina L. ;Dahl, Rebecca M.September 10, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):What is already known about this topic? mRNA COVID-19 vaccines are effective in preventing severe COVID-19 outcomes, including hospitalization.What is...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.